Keywords: Pfizer, Capsugel, FoldRx, Capsules, Drug delivery, Divestiture

Pfizer views options for Capsugel business, including selling the unit; closed FoldRx acquisiton

Article | 07 October 2010

Print This

Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is reviewing strategic alternatives for Capsugel, which may include a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in